ACTIVE_NOT_RECRUITING

Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The CONNECT: "Developing a learning COmmunity to increase eNgagemeNt and Enrollment in cardiovascular Clinical Trials" is comprehensive, participant-centered learning platform designed to increase diversity in cardiovascular disease research among women and Black and Latino adults. CONNECT will deploy electronic health record (EHR)-informed and community-engaged recruitment approaches to identify and recruit adults with cardiovascular disease or a cardiovascular disease risk factor to join CONNECT. Participants who join CONNECT will receive tailored educational information on cardiovascular health and research participation via text message. Participants will also have the opportunity to be connected to ongoing cardiovascular research studies based on basic demographic information and areas of interest. The educational information will be sent to participants for 12 months. The CONNECT platform will be used to evaluate recruitment methods. The investigators hypothesize the proportion of women and Black and Latin adults enrolled in trials that partner with CONNECT will be higher following the use of CONNECT for recruitment. Investigators also hypothesize that participating in CONNECT will increase participants' clinical trial awareness, trust, and willingness to participate in clinical trials.

Official Title

Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials

Quick Facts

Study Start:2024-05-04
Study Completion:2026-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06347484

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participant is 18 years or older
  2. * Residing in the US
  3. * Self-identifies as having cardiovascular disease or cardiovascular risk factors
  4. * Has a mobile phone and is willing to receive text-messages
  5. * Can read in English or Spanish
  1. * Unwilling or unable to provide informed consent

Contacts and Locations

Principal Investigator

Hailey N Miller, PhD, RN
PRINCIPAL_INVESTIGATOR
Johns Hopkins School of Nursing
Cheryl R Dennison Himmelfarb, PhD, RN, ANP
PRINCIPAL_INVESTIGATOR
Johns Hopkins School of Nursing

Study Locations (Sites)

Johns Hopkins University School of Nursing
Baltimore, Maryland, 21205
United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

  • Hailey N Miller, PhD, RN, PRINCIPAL_INVESTIGATOR, Johns Hopkins School of Nursing
  • Cheryl R Dennison Himmelfarb, PhD, RN, ANP, PRINCIPAL_INVESTIGATOR, Johns Hopkins School of Nursing

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-04
Study Completion Date2026-10

Study Record Updates

Study Start Date2024-05-04
Study Completion Date2026-10

Terms related to this study

Keywords Provided by Researchers

  • Recruitment
  • Diversity
  • Inclusion
  • Clinical Trials
  • Cardiovascular Disease
  • Community Engagement
  • Registry
  • Digital Health

Additional Relevant MeSH Terms

  • Cardiovascular Diseases
  • Hypertension
  • Diabetes Type 2
  • Stroke
  • Recruitment
  • Overweight and Obesity
  • Hyperlipidemias